BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

USGI Medical Announces Key Management Appointments


10/13/2008 9:42:21 AM

Bart Bandy Joins USGI as General Manager of Newly-Created Flexible Surgery Division

John Cox Promoted to General Manager of EndoSurgery Division

SAN CLEMENTE, Calif., Oct. 13 /PRNewswire/ -- USGI Medical, Inc. today announced two key management appointments that will help drive the company's leadership in Incisionless surgery.

The company has named Bart Bandy General Manager of its new Flexible Surgery division focused on supplying the company's Incisionless devices to surgeons for use in NOTES (natural orifice translumenal endoscopic surgery) and single-port procedures. Also, the company has announced that John Cox has been promoted to General Manager of EndoSurgery, the division of the company focused on expanding the use of USGI's Incisionless devices within the GI tract.

"John and Bart bring decades of medical device experience to USGI Medical and will lead our efforts to provide surgeons and gastroenterologists with our Incisionless devices that have the potential to revolutionize surgery," said USGI Medical CEO Eugene Chen. "We are extremely pleased to have Bart on board and John in his new leadership role."

Mr. Bandy comes to USGI from Allergan where he most recently served as Senior Vice President of the company's Allergan Health division (formerly Inamed Health). Prior to joining Inamed in 1999, he held various management positions of increased responsibility with Ethicon Endo-Surgery Inc., Karl Storz Endoscopy-America, Inc., and Harris/Lanier Worldwide. He is a past Chairman of the American Society for Bariatric Surgery Corporate Council and previously served as President of the Society of American Gastrointestinal Endoscopic Surgeons Corporate Council.

"Leading surgeons have used USGI's Incisionless surgical tools to pioneer the next evolution of minimally invasive surgery," Mr. Bandy said. "This is only the beginning. I expect our technology to have the similar impact as laparoscopic instruments have had over the past two decades. The USGI EndoSurgical Operating System (EOS) combines the flexibility of endoscopy with the surgical benefits of laparoscopy, giving surgeons access to the internal organs with less pain to the patient and better cosmetic results. I'm extremely pleased to join USGI as it sits at the forefront of surgical innovation."

Mr. Cox, who was previously USGI's Vice President of Sales and Marketing, has over 20 years of experience in medical device marketing, sales, and development. Over the last four years, John has been driving development of the EOS and has been named solo or joint inventor in numerous issued or pending patents. Prior to USGI, Mr. Cox held various management positions with B. Braun Aesculap, Applied Medical, Stryker and U.S. Surgical. In addition, Mr. Cox holds a B.A. from the University of Virginia, and received his MBA with Academic Honors from Virginia's Darden School of Business.

"As we prepare for wider U.S. launch of our Incisionless Platform next year, we see strong demand for surgery without scars and painful incisions giving rise to a whole new breed of "incisionless surgeons" ready to meet that demand. Over the last year, surgeons have used the EOS in a wide variety of procedures, including stoma and pouch reduction in post-bypass patients, fistula closure, and other common GI and surgical procedures," Mr. Cox said. "Incisionless techniques have the potential to augment or replace millions of common invasive procedures across a wide range of applications."

About USGI Medical

USGI Medical is the leader in Incisionless Surgery. USGI's EndoSurgical Operating System(TM) (EOS) provides surgeons the operating platform and specialized tools they need to perform surgery through a patient's mouth or other natural orifices, reducing or eliminating the need for external incisions into the abdomen. Operating through the body's natural orifices offers promise for less pain, shorter hospital stays, reduced risk of wound infection and no external scars -- and is rapidly becoming an option demanded by patients and healthcare providers. USGI offers surgeons and gastroenterologists the technology they need to offer millions of potential patients a less invasive surgical option.

CONTACT: Hollister Hovey, of Lazar Partners, +1-646-871-8482,
hhovey@lazarpartners.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES